Stacey N. Akers

1.4k total citations
22 papers, 813 citations indexed

About

Stacey N. Akers is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Stacey N. Akers has authored 22 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Reproductive Medicine. Recurrent topics in Stacey N. Akers's work include Ovarian cancer diagnosis and treatment (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (5 papers). Stacey N. Akers is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (5 papers). Stacey N. Akers collaborates with scholars based in United States. Stacey N. Akers's co-authors include Kunle Odunsi, Adam R. Karpf, Shashikant Lele, Wa Zhang, Peter J. Frederick, Austin Miller, Paulette Mhawech‐Fauceglia, Emese Zsíros, Sarah Lynam and Kristopher Attwood and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Gynecologic Oncology.

In The Last Decade

Stacey N. Akers

21 papers receiving 806 citations

Peers

Stacey N. Akers

ONCOL

IMMUN

SURGE

Akiyoshi Yamanaka Japan

Joachim Alfer Germany

Mitsunori Matsuo Japan

Jens Ole Eriksen Denmark

Cornelia Bachmann Germany

Erin K. Crane United States

Harry Fisher United States

Charles R. Boice United States

Paola De Sanctis Italy

Stinne Ravn Greisen Denmark

Akiyoshi Yamanaka Japan

Stacey N. Akers

137 ×0.4

146 ×0.5

ONCOL

200 ×0.7

IMMUN

292 ×1.9

68 ×0.5

SURGE

Citations per year, relative to Stacey N. Akers Stacey N. Akers (= 1×) peers Akiyoshi Yamanaka

Countries citing papers authored by Stacey N. Akers

Since Specialization

Citations

This map shows the geographic impact of Stacey N. Akers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey N. Akers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey N. Akers more than expected).

Fields of papers citing papers by Stacey N. Akers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey N. Akers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey N. Akers. The network helps show where Stacey N. Akers may publish in the future.

Co-authorship network of co-authors of Stacey N. Akers

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey N. Akers. A scholar is included among the top collaborators of Stacey N. Akers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey N. Akers. Stacey N. Akers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Wa, David Klinkebiel, Carter J. Barger, et al.. (2020). Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability. Cancers. 12(3). 764–764. 46 indexed citations

Mayor, Paul, Stacey N. Akers, Shashikant Lele, et al.. (2019). Surgery induces broad changes in clinically relevant genes regulating immune and metabolic responses in murine epithelial ovarian cancer. Gynecologic Oncology. 154. 36–36. 2 indexed citations

Morrell, Kayla, Kevin H. Eng, Alan D. Hutson, et al.. (2018). Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery. JAMA Network Open. 1(8). e185452–e185452. 88 indexed citations

Phoenix, David A., Kayla Morrell, Kevin H. Eng, et al.. (2018). Tackling the opioid crisis: Implementation of an ultra-restrictive opioid prescription protocol in patients undergoing major gynecologic surgery radically decreased dispensed opioid without reducing pain control. Gynecologic Oncology. 149. 5–5. 5 indexed citations

Starbuck, Kristen, Kevin H. Eng, Kayla Morrell, et al.. (2018). Prognostic impact of adjuvant chemotherapy treatment delays for ovarian cancer: A cohort study. Gynecologic Oncology. 149. 127–128.

Starbuck, Kristen, Kayla Morrell, Kunle Odunsi, et al.. (2018). TIGIT ligands CD155, CD112, and galectin-9 are associated with immune infiltration and increased overall survival in ovarian cancer. Gynecologic Oncology. 149. 56–56. 1 indexed citations

Starbuck, Kristen, Kayla Morrell, Emese Zsíros, et al.. (2018). Proton pump inhibitor use during chemotherapy for platinum-resistant or platinum-refractory ovarian cancer improves overall survival. Gynecologic Oncology. 149. 68–68. 3 indexed citations

Klinkebiel, David, Wa Zhang, Stacey N. Akers, Kunle Odunsi, & Adam R. Karpf. (2016). DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer. Molecular Cancer Research. 14(9). 787–794. 36 indexed citations

Strohl, Anna E., Stacey N. Akers, Wiam Bshara, et al.. (2016). Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease. Journal of Ovarian Research. 9(1). 75–75. 14 indexed citations

10.

Szender, J. Brian, K.S. Grzankowski, Stacey N. Akers, et al.. (2016). Evaluation of the impact of chronic steroid use on outcomes in gynecologic cancer patients: A NSQIP database analysis. Gynecologic Oncology. 141. 169–169. 1 indexed citations

11.

Zhang, Wa, Carter J. Barger, Petra A. Link, et al.. (2015). DNA hypomethylation-mediated activation ofCancer/Testis Antigen 45(CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics. 10(8). 736–748. 50 indexed citations

12.

Szender, J. Brian, Peter J. Frederick, Kevin H. Eng, et al.. (2015). Evaluation of the National Surgical Quality Improvement Program Universal Surgical Risk Calculator for a Gynecologic Oncology Service. International Journal of Gynecological Cancer. 25(3). 512–520. 34 indexed citations

13.

Odunsi, Kunle, Junko Matsuzaki, Smitha R. James, et al.. (2014). Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer. Cancer Immunology Research. 2(1). 37–49. 153 indexed citations

14.

Akers, Stacey N., Kirsten B. Moysich, Wa Zhang, et al.. (2013). LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. Gynecologic Oncology. 132(2). 462–467. 40 indexed citations

15.

Mori, Kenichi, Stacey N. Akers, Wiam Bshara, et al.. (2013). Gamma synuclein expression in ovarian cancer. Gynecologic Oncology. 131(1). 272–272. 2 indexed citations

16.

Akers, Stacey N., et al.. (2013). Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study.. PubMed. 34(2). 113–9. 6 indexed citations

17.

Woloszynska‐Read, Anna, Wa Zhang, Jihnhee Yu, et al.. (2011). Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage. Clinical Cancer Research. 17(8). 2170–2180. 68 indexed citations

18.

Mhawech‐Fauceglia, Paulette, Joshua P. Kesterson, Dan Wang, et al.. (2011). Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer. Histopathology. 59(1). 63–72. 22 indexed citations

19.

Rodabaugh, Kerry J., et al.. (2011). Prospective analysis of chemotherapy-induced neuropathy in patients with gynecologic malignancies.. Journal of Clinical Oncology. 29(15_suppl). e19737–e19737. 1 indexed citations

20.

Akers, Stacey N., Kunle Odunsi, & Adam R. Karpf. (2010). Regulation of Cancer Germline Antigen Gene Expression: Implications for Cancer Immunotherapy. Future Oncology. 6(5). 717–732. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact